Myobloc Botulinum Toxin Type B Injectable Solution Trademark Details

Myobloc Botulinum Toxin Type B Injectable Solution was registered on Tuesday, October 22, 2002 and is currently owned by Solstice Neurosciences, Inc. under the registration number 2639583 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 15 years ago on Saturday, May 30, 2009, according to the United State Patent & Trademark Office
Word Mark Myobloc Botulinum Toxin Type B Injectable Solution
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Solstice Neurosciences, Inc. of Malvern, PA

View all trademarks for Solstice Neurosciences, Inc.
Other Trademarks for Solstice Neurosciences, Inc.

Previous Owners

Elan Pharmaceuticals, Inc. of South San Francisco, CA

View all trademarks for Elan Pharmaceuticals, Inc.
Other Trademarks for Elan Pharmaceuticals, Inc.
Serial Number 78039531
Registration Number 2639583
Status Date Saturday, May 30, 2009
Filing Date Saturday, May 30, 2009
Registration Date Tuesday, October 22, 2002
Attorney Laura Newman Sciarrino

Correspondent

Raymond I. Geraldson, Jr.
Pattishall McAuliffe Newbury Hilliard &
Suite 5000
311 S. Wacker Drive
Chicago IL 60606

Case File Statements

Disclaimer with Predetermined Text "BOTULINUM TOXIN TYPE B" and "INJECTABLE SOLUTION"
Description of Mark The mark consists of a check and a circle together with the words "MYOBLOC BOTULINUM TOXIN TYPE B INJECTABLE SOLUTION".
Goods & Services Pharmaceutical Preparations for the Treatment of Neuromuscular Disorders

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 2 — Sec. 8 – Entire Registration
Status Date Saturday, May 30, 2009
First Use Anywhere Wednesday, December 27, 2000
First Use In Commerce Wednesday, December 27, 2000
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.